These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 2040105

  • 1. Influence of biological response modifiers of bacterial origin on disease progression in the MRL-lpr model of systemic lupus erythematosus.
    Hart DA, Krause G, Martin L, Garlepp M, Fritzler MJ.
    Clin Invest Med; 1991 Feb; 14(1):55-62. PubMed ID: 2040105
    [Abstract] [Full Text] [Related]

  • 2. Plasma proteinase regulation during disease progression in murine models of SLE.
    Hart DA, Garlepp M, Fritzler M.
    J Clin Lab Immunol; 1989 Sep; 30(1):27-34. PubMed ID: 2701743
    [Abstract] [Full Text] [Related]

  • 3. Regulation of plasma complement C4 and factor b levels in murine systemic lupus erythematosus.
    Garlepp MJ, Hart DA, Fritzler MJ.
    J Clin Lab Immunol; 1989 Mar; 28(3):137-41. PubMed ID: 2738911
    [Abstract] [Full Text] [Related]

  • 4. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
    Lu Q, Shen N, Li XM, Chen SL.
    Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
    [Abstract] [Full Text] [Related]

  • 5. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

  • 6. Alterations in hypothalamic-pituitary-adrenal function correlated with the onset of murine SLE in MRL +/+ and lpr/lpr mice.
    Shanks N, Moore PM, Perks P, Lightman SL.
    Brain Behav Immun; 1999 Dec; 13(4):348-60. PubMed ID: 10600221
    [Abstract] [Full Text] [Related]

  • 7. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ.
    J Immunol; 1998 Dec 15; 161(12):6999-7006. PubMed ID: 9862736
    [Abstract] [Full Text] [Related]

  • 8. Age and lpr dependent induction of increased sensitivity to the toxic effects of lipopolysaccharide and indomethacin in MRL mice: evidence for RES activation during disease progression.
    Hart DA.
    J Clin Lab Immunol; 1988 Jul 15; 26(3):129-34. PubMed ID: 3230580
    [Abstract] [Full Text] [Related]

  • 9. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL, Cohen P, Williams D, O'Brien K, Volkman A, Eisenberg R.
    J Immunol; 1993 Jan 15; 150(2):695-9. PubMed ID: 8419494
    [Abstract] [Full Text] [Related]

  • 10. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 15; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 11. Immunopathology of murine lupus-overview, SL/Ni and MRL/Mp-lpr/lpr-.
    Kyogoku M, Nose M, Sawai T, Miyazawa M, Tachiwaki O, Kawashima M.
    Prog Clin Biol Res; 1987 Dec 15; 229():95-130. PubMed ID: 3601997
    [Abstract] [Full Text] [Related]

  • 12. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
    Apelgren LD, Bailey DL, Fouts RL, Short L, Bryan N, Evans GF, Sandusky GE, Zuckerman SH, Glasebrook A, Bumol TF.
    Cell Immunol; 1996 Oct 10; 173(1):55-63. PubMed ID: 8871601
    [Abstract] [Full Text] [Related]

  • 13. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.
    Choi JY, Gao W, Odegard J, Shiah HS, Kashgarian M, McNiff JM, Baker DC, Cheng YC, Craft J.
    Arthritis Rheum; 2006 Oct 10; 54(10):3277-83. PubMed ID: 17009262
    [Abstract] [Full Text] [Related]

  • 14. Influence of Corynebacterium parvum-PER on disease progression in the NZB/W model of systemic lupus erythematosus.
    Krause G, Martin L, Fritzler M, Hart DA.
    Int J Immunopharmacol; 1992 Jan 10; 14(1):35-41. PubMed ID: 1582732
    [Abstract] [Full Text] [Related]

  • 15. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
    Klinman DM.
    J Immunol; 1990 Apr 01; 144(7):2529-34. PubMed ID: 2108205
    [Abstract] [Full Text] [Related]

  • 16. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb 01; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 17. MRL/lpr lupus-prone mice show exaggerated ICAM-1-dependent leucocyte adhesion and transendothelial migration in response to TNF-alpha.
    Marshall D, Dangerfield JP, Bhatia VK, Larbi KY, Nourshargh S, Haskard DO.
    Rheumatology (Oxford); 2003 Aug 01; 42(8):929-34. PubMed ID: 12730527
    [Abstract] [Full Text] [Related]

  • 18. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Autosomal loci associated with a sex-related difference in the development of autoimmune phenotypes in a lupus model.
    Misu N, Zhang M, Mori S, Miyazaki T, Furukawa H, Sasaki T, Nose M, Ono M.
    Eur J Immunol; 2007 Oct 15; 37(10):2787-96. PubMed ID: 17823981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.